Loading organizations...
Loading organizations...
Biopharmaceutical company developing targeted CAR-T therapeutics.
Poseida Therapeutics has raised $312.5M across 4 funding rounds.
Poseida Therapeutics has raised $312.5M in total across 4 funding rounds.
Poseida Therapeutics has raised $312.5M in total across 4 funding rounds.
Poseida Therapeutics's investors include Fidelity Management & Research Company, Adage Capital Management, Schonfeld Strategic Advisors, Novartis Pharma, Aisling Capital, Boxer Capital, Longitude Capital, Malin Corporation, Pentwater Capital Management, Perceptive Advisors, Vivo Capital, David Hirsch.
Poseida Therapeutics has raised $312.5M across 4 funding rounds. Most recently, it raised $110.0M Series D in June 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 25, 2020 | $110.0M Series D | Fidelity Management & Research Company | Adage Capital Management, Schonfeld Strategic Advisors |
| Apr 22, 2019 | $142.0M Series C | Novartis Pharma | Aisling Capital, Boxer Capital, Longitude Capital, Malin Corporation, Pentwater Capital Management, Perceptive Advisors, Vivo Capital |
| Apr 3, 2018 | $30.5M Series B | David Hirsch | Malin Corporation, Tavistock Group, Vivo Capital |
| Dec 16, 2015 | $30.0M Series A | Adrian Howd |